Sunday, November 1, 2026

After Heart Surgery, This Dog Needed a Human Touch — Even a Fake One

A dog named Peanut found comfort from a hand model during recovery from heart surgery, lowering anxiety and blood pressure.

The Easiest Way To Lose Investor Trust? Just Steal $6.7 Billion! BMS Masterclass In Bad Business

Bristol Myers Squibb faces a $6.7B lawsuit over alleged delays in drug approvals affecting former Celgene shareholders' payouts.

North Korean Nuclear Missiles Could Hit the United States, Says Assistant Secretary of Defense

North Korea's nuclear threat is growing, prompting the U.S. to invest in advanced defense systems like "Golden Dome for America."

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

SK Chemicals and J2H Biotech Partner for Breakthrough MASH Treatment: What You Need to Know

SK Chemicals partners with J2H Biotech to develop J2H-1702, a treatment for metabolic-associated steatotic liver disease, enhancing drug pipeline.

Unlocking Cancer Treatment: Samsung Bioepis Achieves Keytruda Biosimilar Equivalence in Global Trials

Samsung Bioepis' biosimilar SB27 shows equivalence to Keytruda in key clinical trials, enhancing access to cancer immunotherapy.

High cost keeps breakthrough VHL drug out of reach for Korean patients, oncologist says

Patients with Von Hippel-Lindau syndrome face high treatment costs, limiting access to essential drugs like Welireg, which could reduce surgeries.

Seers wins FDA clearance for wearable ECG device, accelerating U.S. expansion

Seers' mobiCARE™ ECG monitor received FDA clearance, accelerating U.S. market entry and enhancing global expansion plans.

Continuous glucose monitors linked to 62% lower risk of death in Type 1 diabetes patients, study finds

A Korean study shows continuous glucose monitoring significantly reduces complications and mortality in Type 1 diabetes patients.

Top 10 Breakthrough Research Projects from the 2026 UST Proposal Challenge

UST's Proposal Challenge showcased innovative student research aimed at solving social issues, with awards for top proposals in various fields.

Understanding Iron Deficiency Anemia: Symptoms, Risks, and Prevention Tips

Anemia, especially iron deficiency, can lead to fatigue and serious health issues. Early diagnosis and treatment are crucial.

Korea Rising: How South Korea is Shaping the Future of the Global Bioindustry at BIO International Convention 2026

Korea's bioindustry showcased its innovations at BIO USA 2026, emphasizing global collaboration and the need for diverse business models.

‘Mom, Dad’ and Ball Kicks…’Human Theater’ Quintuplets Show Remarkable Growth

Quintuplets born prematurely at 27 weeks show healthy development at 18 months, thanks to dedicated care and monitoring.

[Lillie report] Lilly’s Pacific-facing innovation hub brings K-biotech future to Songdo

Lilly Gateway Labs in San Diego supports early-stage biotechs, expanding to Korea with Samsung Biologics to foster innovation.

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

Partnering Hits 180 Meetings, 2,000 Visitors…Celltrion Showcases AI and ADC Strength at BIO USA

Celltrion showcased AI-driven drug development at BIO USA, holding 180 meetings and emphasizing partnerships in antibody programs.

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

GCCL Strengthens Global Clinical Trial Role: What This Means for Asia’s Biotech Industry?

GCCL aims to expand internationally as a central lab for clinical trials, enhancing services and leveraging competitive advantages.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.